TERESA ACOSTA: Open Payments
NPI 1871015628 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 9 payments from 8 companies in 2025. Trend: 2023 $4,230 · 2024 $87 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| PFIZER INC. | 1 | $18 |
| GENZYME CORPORATION | 1 | $17 |
| Electromed, Inc. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: DUPIXENT, TAGRISSO, QULIPTA, MOUNJARO, TEZSPIRE, PREVNAR 20, SMARTVEST, JARDIANCE.
Industry payments across TN — which companies pay providers there.
